ROBINS JASON SHAND (Interim CFO) received a stock award from OCULAR THERAPEUTIX, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/12/2026ACC: 0001104659-26-073586
Officer· Interim CFO
Since Jan 2026
+29.46K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
29.46K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+15.44K
Price / share
—
Trade value
—
% of position
29.3%
6/10/2026
52.66K→68.10K
Total
Net shares
+15.44K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/10/2026 | A · Award | +15.44K | — | — | 29.3% | 52.66K | 68.10K |
| Total | +15.44K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
14.02K shares
Shares
+14.02K
Strike price
8.74
Held after
14.02K
Exercisable
—
6/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock14.02K shares | 6/10/2026 | A · Award | +14.02K | 8.74 | — | 14.02K |